News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Team Japan enters the Uromigos
Photo from Uromigos/X
Jun 11, 2024, 15:42

Team Japan enters the Uromigos

Uromigos shared a post on X/Twitter:

”Team Japan enters the Uromigos to beat team LA in Nashville. Nobuaki Matsubara, Hiroshi Kitamura and Yuji Miura battle through sometimes ridiculous questions ranging from Sumo wrestling to axitinib PK data. Can they beat Canada?”

Read further.
Source: Uromigos/X

cancer Hiroshi Kitamura Nobuaki Matsubara OncoDaily Oncology Uromigos Yuji Miura
Special Coverage
Blog
May 9, 2025, 14:34
Maria Concetta La Milia: Patient-Reported Outcomes in Nose Vestibule Interventional Radiotherapy at ESTRO2025
Blog
May 9, 2025, 14:19
Josh Thomas Georgy Highlights DESTINY-Breast11 Results in High-Risk HER2+ Early Breast Cancer
Blog
May 9, 2025, 14:18
Half of Patients Diagnosed With Cancer in 2023 Had a History of Smoking - CRI
Blog
May 9, 2025, 14:08
Aligning Incentives for Value-Based Success: Building Sustainable Oncology Partnerships - CancerX
Blog
May 9, 2025, 14:06
Childhood Cancer at Survivor’s Week 2025: A Celebration of Strength and New Beginnings
Blog
May 9, 2025, 14:01
Meet the ASCO25 Featured Voices
Blog
May 9, 2025, 13:59
Arturo LoAIza-Bonilla: How AI and Digital Platforms are Transforming Patient Adherence and Real-Time Decision Support
Insight
May 9, 2025, 13:55
FDA Announces Aggressive Timeline to Scale 1st AI-Assisted Scientific Review Pilot
Blog
May 9, 2025, 13:49
Fernando Goldsztein: A Time to Raise Awareness about Brain Tumors
Blog
May 9, 2025, 13:46
Small Cell Lung Cancer Progress: Insights from LUNGevity's Executive Director
Blog
May 9, 2025, 13:37
Helena Linardou: Exciting afternoon at the 2025 AI for Oncology Congress
Opinion
May 9, 2025, 13:29
Galip Can Uyar: Prophylactic oophorectomy boosts survival by up to 50% in young women with BRCA mutations